Elodie
Elodie Aumaitre, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20100112139 | Foaming Agents Comprising Hydrophobin - Gelled particles having a largest dimension of more than 0.1 μm which are coated with hydrophobin are provided. Aerated and aeratable compositions comprising the particles are also provided. | 05-06-2010 |
Elodie Barbagallo, Paris FR
Patent application number | Description | Published |
---|---|---|
20120129864 | SUBSTITUTED 1-ALKYLCINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION OF SAME - The subject of the present invention is compounds corresponding to the formula (I) in which: X represents a divalent (C | 05-24-2012 |
Elodie Barbagallo, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20110144115 | SUBSTITUTED 1-BENZYL-CINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF - The present invention is related to novel substituted 1-benzylcinnolin-4(1H)-one derivatives having affinity for cannabinoid CB | 06-16-2011 |
Elodie Barbau-Piednoir, Meung Sur Loire FR
Patent application number | Description | Published |
---|---|---|
20100120032 | TRANSGENIC PLANT EVENT DETECTION - The present invention relates to detection of materials derived from transgenic plant events. In particular, the invention provides methods, reagents, kits and reference materials for detecting the presence or absence in a sample of genetic material derived from and attributable to select transgenic plant events. | 05-13-2010 |
20140220571 | TRANSGENIC PLANT EVENT DETECTION - The present invention relates to detection of materials derived from transgenic plant events. In particular, the invention provides methods, reagents, kits and reference materials for detecting the presence or absence in a sample of genetic material derived from and attributable to select transgenic plant events. | 08-07-2014 |
Elodie Bouny, Gueret FR
Patent application number | Description | Published |
---|---|---|
20130229612 | MULTIPLE GLAZING WITH VARIABLE SCATTERING BY LIQUID CRYSTALS AND ITS METHOD OF MANUFACTURE - A multiple glazing with variable scattering by liquid crystals includes first and second flat float glass sheets sealed on the edge of their internal faces by a sealing joint, in particular made of a given sealing material, in particular essentially organic, first and second electrodes, and a layer of liquid crystals with an average thickness E between 15 and 60 μm inclusive of these values and incorporating spacers. The thickness A of each of the first and second glass sheets is less than or equal to 5.5 mm, and each of the internal faces coated with the first and second electrodes has a dioptric defect score, expressed in millidioptres, of less than 12E/15 where the thickness E of the liquid crystals is in μm. | 09-05-2013 |
20130265511 | MULTIPLE GLAZING HAVING VARIABLE DIFFUSION BY LIQUID CRYSTALS, AND METHOD FOR MANUFACTURING SAME - A liquid-crystal multiple glazing including a first glass sheet and a second glass sheet that is sealed by a sealing gasket, first and second electrodes with first and second electricity supply zones, a liquid-crystal layer, between 15 and 60 μm, with spacers, the first glass sheet protruding by a first protruding side and including the first electricity supply zone, electrical cabling with a first cabling input with a first electrically insulating polymer material, a third glass sheet laminated with the second glass sheet, the third glass sheet protruding from the second glass sheet by a side covering the first electrically insulating material, referred to as the first covering side. | 10-10-2013 |
20150098037 | MULTIPLE GLAZING WITH VARIABLE SCATTERING BY LIQUID CRYSTALS AND ITS METHOD OF MANUFACTURE - A multiple glazing with variable scattering by liquid crystals includes first and second flat float glass sheets sealed on the edge of their internal faces by a sealing joint, in particular made of a given sealing material, in particular essentially organic, first and second electrodes, and a layer of liquid crystals with an average thickness E between 15 and 60 μm inclusive of these values and incorporating spacers. The thickness A of each of the first and second glass sheets is less than or equal to 5.5 mm, and each of the internal faces coated with the first and second electrodes has a dioptric defect score, expressed in millidioptres, of less than 12 E/15 where the thickness E of the liquid crystals is in μm. | 04-09-2015 |
Elodie Bourgeat-Lami, Nievroz FR
Patent application number | Description | Published |
---|---|---|
20150315070 | TRANSPARENT SUBSTRATE, IN PARTICULAR A GLASS SUBSTRATE, COATED WITH AT LEAST ONE AT LEAST BIFUNCTIONAL POROUS LAYER, MANUFACTURING METHOD AND USES THEREOF - A transparent glass or ceramic or glass-ceramic substrate, coated with a functional layer or with a stack of at least two functional layers, the functional layer or at least one of the functional layers of the stack being porous and made of an inorganic material M1, wherein the or at least one of the porous functional layer(s) of inorganic material M1 has, at the surface of at least one portion of the pores thereof, at least one inorganic material M2 different from M1. | 11-05-2015 |
Elodie Brient-Litzler, Versailles FR
Patent application number | Description | Published |
---|---|---|
20100291586 | METHOD FOR THE DIAGNOSIS OR THE SCREENING OF AN ARBOVIRUS INFECTION, REAGENTS USEFUL IN SAID METHOD AND THEIR APPLICATIONS - Method for the diagnosis or the screening of an arbovirus infection and preferably a flaviviridae infection and more preferably a flavivirus infection, reagents useful in said method and their applications. Said method comprises: (i) contacting a sample from the subject or animal with a solid support sensitized with an Ig binding protein which is directed against a specific class of Ig molecules of the subject or animal species under consideration and (ii) incubating the immunocomplex formed in (i) with a detector molecule consisting of a hybrid protein comprising at least an arboviral ED3 domain and an alkaline phosphatase (PhoA), the detection of said immunocomplex being the sign of the presence of an arbovirus in said sample. | 11-18-2010 |
20110262964 | Reagentless fluorescent biosensors comprising a designed ankyrin repeat protein module, rational design methods to create reagentless fluorescent biosensors and methods of their use - The present invention relates to reagentless fluorescent biosensors which comprise at least one ankyrin repeat and a fluorophore and are specific for at least one target; the method for preparing such reagentless fluorescent biosensors comprises the following steps: (a) identifying the residues (R | 10-27-2011 |
Elodie Bugnicourt, Freising DE
Patent application number | Description | Published |
---|---|---|
20150225152 | WHEY PROTEIN COATED FILMS - The present invention relates to a process for preparing a whey-protein coated substrate film for packaging, the whey-protein coated substrate obtainable by the process according to the invention, and the packaging film comprising at least one or more of the whey protein coated substrates. | 08-13-2015 |
Elodie Burty, Sourcieux-Les-Mines FR
Patent application number | Description | Published |
---|---|---|
20140234852 | HUMAN KERATINOCYTES PTCH1 CELL LINE - A cellular model is described for targeting dysregulation or inappropriate activation of the Sonic Hedgehog/Patched (SHH/PTCH) pathway. Also described, is a screening method using this cellular mod& to screen for pharmacological compounds that can treat or prevent skin cancer and, in particular, Basal Cell Carinoma (BCC) lesions. | 08-21-2014 |
20140235856 | FIBROBLASTS CELLULAR MODEL FOR ASSESSING EFFICACY OF CANCER TREATMENTS BY SHH/PTCH PATHWAY ANTAGONISTS - A cellular model is described that targets dysregulation or inappropriate activation of the Sonic Hedgehog/Patched (SHH/PTCH) pathway. Also described, is a screening method using this cellular model to screen for pharmacological compounds that can treat or prevent skin cancer, in particular, Basal Cell Carcinoma, (BCC) lesions. | 08-21-2014 |
20140243523 | HUMAN EPITHELIAL CELL LINE FOR 3-D MODELIZING OF CANCER AND TREATMENT THEREOF - A cellular model is described that targets dysregulation or inappropriate activation of the Sonic Hedgehog/Patched (SHH/PTCH) pathway. Also described, is a screening method using this cellular model to screen for pharmacological compounds that can treat or prevent skin cancer, in particular, Basal Cell Carcinoma (BCC) lesions. | 08-28-2014 |
Elodie Cansot, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20100134800 | METHOD FOR CALIBRATING INTERPIXEL GAINS OF AN INTERFEROMETER - A method is provided to calibrate a detection array used for acquiring an image of an interferogram at an instrument. A first interferogram and at least two shifted interferograms are elaborated at the instrument by creating a number of optical path differences, so at least three samples are on a sine wave portion for each optical path difference. A function coinciding with the sine wave portion is determined by interpolation. A calibration coefficient is determined from the function for each optical path difference. | 06-03-2010 |
20110199616 | PROCESS AND INSTRUMENT FOR RECONSTRUCTION OF AN IRREGULARLY SAMPLED NARROW-BAND SIGNAL - According to a first aspect the invention relates to a reconstruction process of a narrow-band signal acquired by an instrument producing irregular sampling, in which two series of samples are acquired at the same sampling period, the two series being offset relative to one another such that the sampling errors are identical or quasi identical over both series. According to a second aspect, the invention relates to an instrument configured to carry out the process according to the first aspect of the invention. | 08-18-2011 |
Elodie Chauvot, Ecuisses FR
Patent application number | Description | Published |
---|---|---|
20080281072 | Caprolactam-Based Composition, Process for Manufacturing an Impermeable Element, and Tank - The present invention relates to a composition that can be used to manufacture an impermeable, sealing, tight envelope, to a process for manufacturing an impermeable envelope, and to a tank. The composition of the invention comprises in % by weight relative to the total weight of the composition: from 70 to 90% of a monomer (I); from 0.1 to 1% of an activator (II), in which R is chosen from the group comprising C | 11-13-2008 |
20140127431 | Caprolactam-Based Composition, Process for Manufacturing an Impermeable Element, and Tank - The present invention relates to a composition that can be used to manufacture an impermeable, sealing, tight envelope, to a process for manufacturing an impermeable envelope, and to a tank. The composition of the invention comprises in % by weight relative to the total weight of the composition: from 70 to 90% of a monomer (I); from 0.1 to 1% of an activator (II), in which R is chosen from the group comprising C | 05-08-2014 |
20140127432 | Caprolactam-Based Composition, Process for Manufacturing an Impermeable Element, and Tank - The present invention relates to a composition that can be used to manufacture an impermeable, sealing, tight envelope, to a process for manufacturing an impermeable envelope, and to a tank. The composition of the invention comprises in % by weight relative to the total weight of the composition: from 70 to 90% of a monomer (I); from 0.1 to 1% of an activator (II), in which R is chosen from the group comprising C | 05-08-2014 |
Elodie Constanciel, Lyon Cedex 03 FR
Patent application number | Description | Published |
---|---|---|
20140024923 | TRANSOESOPHAGEAL DEVICE USING HIGH INTENSITY FOCUSED ULTRASOUNDS FOR CARDIAC THERMAL ABLATION - The present invention relates to a probe that comprises a piezoelectric therapy transducer having an acoustic axis BB′, and an imaging transducer having an imaging plane, in which the therapy transducer and imaging transducer are mounted in a head which is itself connected to a guide. More particularly, the therapy transducer is in a form of a truncated cup and has a spherical concave front face for emitting ultrasonic waves focused on a focal point, a rear surface and the therapy transducer is truncated alone two parallel lanes such that a length d | 01-23-2014 |
Elodie Couplan, Brest FR
Patent application number | Description | Published |
---|---|---|
20120329834 | COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES - The present invention relates to the use of compounds of general formula (I): (I) for the preparation of medicaments that act against mitochondrial pathologies involving a deficiency in ATP production via the oxidative phosphorylation pathway, such as mitochondrial diseases. | 12-27-2012 |
Elodie Crublet, L'Albenc FR
Patent application number | Description | Published |
---|---|---|
20130309747 | MGMT-BASED METHOD FOR OBTAINING HIGH YEILDS OF RECOMBINANT PROTEIN EXPRESSION - The present invention relates to a novel enhancer of protein production in host cells. It discloses a vector for expressing recombinant proteins in these cells, comprising a nucleotide sequence encoding a) a secretion peptidic signal, b) a 6-methylguanine-DNA-methyltransferase enzyme (MGMT, EC 2.1.1.63), a mutant or a catalytic domain thereof, and c) a recombinant protein. Said MGMT enzyme is preferably the so-called SNAP protein. | 11-21-2013 |
Elodie Degout-Charmette, Toussieux FR
Patent application number | Description | Published |
---|---|---|
20140127734 | METHOD OF DETECTING AT LEAST ONE MECHANISM OF RESISTANCE TO CEPHALOSPORINS BY MASS SPECTROMETRY - The present invention pertains to a method of detection, by mass spectrometry, of at least one marker of at least one mechanism of resistance to at least one antimicrobial, resistance of at least one microorganism contained in a sample, characterised in that the antimicrobial is a cephalosporin, and said resistance markers are proteins or peptides. Preferably, said proteins or peptides are proteins from said microorganism. | 05-08-2014 |
20150031063 | METHOD OF DETECTING AT LEAST ONE MECHANISM OF RESISTANCE TO CARBAPENEMS BY MASS SPECTROMETRY - The present invention pertains to a method of detection, by mass spectrometry, of at least one marker of at least one mechanism of resistance to at least one antimicrobial, resistance of at least one microorganism contained in a sample, characterised in that the antimicrobial is a carbapenem, and said resistance markers are proteins or peptides. Preferably, said proteins or peptides are proteins from said microorganism. | 01-29-2015 |
Elodie Ducourthial, Compiegne FR
Patent application number | Description | Published |
---|---|---|
20140212639 | COMPOSITION THAT CAN BE SCREEN PRINTED ONTO POLYVINYL BUTYRAL - The invention relates to | 07-31-2014 |
20150210872 | COLOURED COMPOSITION SCREEN-PRINTABLE ON A SHEET OF POLYMER MATERIAL - A laminated glazing includes a sheet of polymer material color printed, via screen printing, using a composition including 10% to 15% by weight of polyvinyl butyral; 32% to 45% by weight of at least one solvent predominantly consisting of at least one aliphatic dicarboxylic acid diester, and at least one white pigment in an amount and with a specific surface area that are selected so that the Brookfield viscosity of the composition at 20° C. is between 9 and 13 Pa·s. | 07-30-2015 |
Elodie Hablot, Mangiennes FR
Patent application number | Description | Published |
---|---|---|
20150291741 | POLYOLS FROM PROTEIN BIOMASS - A process of producing multi-hydroxy polyols, the process comprising providing a biomass material and transamidating the biomass material with an amine selected from the group consisting essentially of a diamine and an alkanolamine, to provide low molecular weight derived amino-acids or derived oligomers of proteins. Thereafter, reacting the derived amino-acids or derived oligomers with a carbonate to provide hydroxyl terminated urethane oligomers. | 10-15-2015 |
Elodie Hablot, Lansing, MI US
Patent application number | Description | Published |
---|---|---|
20140171535 | POLYOLS FROM BIOMASS AND POLYMERIC PRODUCTS PRODUCED THEREFROM - Polyol compositions containing methane linkages derived from amino acids. The polyols are obtained from the reaction of the carbonate with the cadres in the amino acids. Individual amino acids or mixtures of amino acids that are prepared from the hydrolysis of the proteins can be used. | 06-19-2014 |
Elodie Halbot, Lansing, MI US
Patent application number | Description | Published |
---|---|---|
20140194567 | INTERPENETRATING POLYMER NETWORKS DERIVED FROM SILYLATED TRIGLYCERIDE OILS AND POLYSILOXANES - A composition of matter comprising an interpenetrating polymer network of a combination of a silanol-containing polysiloxane phase and a silylated triglyceride oil phase. The two phases are mixed and covalently bound to each other via siloxane crosslinks. A method for producing interpenetrating polymer networks. The method comprises providing triglycerides from oils or fats and reacting the triglycerides with a reactive silane to form a silylated triglyceride oil. The silylated triglyceride oil and a silanol terminated polysiloxane are emulsified with water in a predetermined ratio. Thereafter, crosslinking agents are added and the water is removed from the emulsions providing siloxane crosslinks between the two intimately mixed immiscible phases. | 07-10-2014 |
Elodie Hellaby, Saint-Laure FR
Patent application number | Description | Published |
---|---|---|
20110014321 | METHOD FOR MAKING DECONTAMINATED BAKERY PRODUCTS, DECONTAMINATED BAKERY PRODUCTS, AND DEVICE FOR IMPLEMENTING SAID METHOD - Method for making decontaminated bakery products, including the following, preferably consecutive, steps: (1) preparing a dough by mixing: A. flour; B. water; C. optionally fat(s); D. at least one fermentation agent; E. NaCl; F. optionally sugar(s); G. at least one filler agent; H. at least one bread-making enhancer including an acid and/or acid salt of gluconodelta-lactone (GDL); I. optionally one low sodium content mixture of minerals; J. optionally one or more additives; (2) shaping the dough; (3) fermenting the dough; (4) at least partially baking the dough; (5) optionally cooling the bread; (6) decontaminating the bread by pumped-light processing; (7) optionally slicing the bread; packaging, preferably into bags. Also disclosed is a bakery product free of any additional chemical preservatives of the E200 type or without vaporization of an ethanol-containing liquid, that has an extended shelf-life, and a device for implementing the method. | 01-20-2011 |
Elodie Kienlen, Hattingen DE
Patent application number | Description | Published |
---|---|---|
20110178137 | DIARYL UREA FOR TREATING HEART FAILURE - The present invention relates to pharmaceutical compositions and combinations for treating, preventing or managing heart failure and/or connected diseases therewith comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide optionally combined with at least one additional therapeutic agent. | 07-21-2011 |
20110263657 | DIARYL UREAS FOR TREATING HEART FAILURE - The present invention relates to pharmaceutical compositions for treating, preventing or managing heart failure and/or connected diseases therewith comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a diaryl urea compound. | 10-27-2011 |
Elodie Lages, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20120322680 | USE OF MIRNAS AS BIOMARKERS IN GLIOMA DIAGNOSIS - The present application relates to the use of miRNAs as biomarkers in glioma diagnosis. It also relates to the use of miRNAs as biomarkers in glioblastoma and oligodendroglioma diagnosis. | 12-20-2012 |
20130330727 | INTRA-TISSUE IN VITRO DIAGNOSIS METHOD FOR DIAGNOSING BRAIN TUMOURS - An in vitro diagnostic method for diagnosing a brain tumour belonging to the group formed by two types of tumours: ODGs and GBMs, and for identifying the type of tumour, the method includes the measurement of at least two ratios of the expression levels of miRNA pairs extracted from a biological sample originating from a patient suspected of presenting one of the above-mentioned brain tumours. | 12-12-2013 |
Elodie Macho Fernandez, Lille FR
Patent application number | Description | Published |
---|---|---|
20150374734 | ACTIVATION OF iNKT CELLS - The present invention relates to particulate entity, such as a nanoparticle or conjugate, for use in particular as adjuvant in vaccine or immunotherapy. More specifically, the invention relates to a particulate entity comprising: iv. an iNKT cell agonist such as α Gal Car compound, and, v. one or more antigenic determinant(s) such as a tumour antigen(s) or pathogen-derived antigen(s), vi. a targeting agent that targets in vivo said iNKT cell agonist to dendritic cells, such as human BDCA3+ dendritic cells. | 12-31-2015 |
Elodie Manie, Paris FR
Patent application number | Description | Published |
---|---|---|
20150140122 | METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS - The invention relates to methods for detecting inactivation of the DNA Homologous Recombination pathway in a patient, and in particular for detecting BRCA1 inactivation. | 05-21-2015 |
Elodie Mery De Montigny, Lyon FR
Patent application number | Description | Published |
---|---|---|
20160042822 | Methods for Simulating the Flow of a Fluid in a Vessel of a Nuclear Reactor and for Calculating the Mechanical Deformation of Assemblies of a Nuclear Reactor Core, and Associated Computer Program Products - A method for simulating the fluid flow in a vessel of a nuclear reactor is provided. The reactor includes a core inside the vessel, the core including a lower plate, an upper plate and fuel assemblies extending between the plates, and having a volume axially delimited by first and second interfaces corresponding to the plates. | 02-11-2016 |
20160042823 | METHODS FOR SIMULATING THE FLOW OF A FLUID IN A VESSEL OF A NUCLEAR REACTOR AND FOR CALCULATING THE MECHANICAL DEFORMATION OF ASSEMBLIES OF A NUCLEAR REACTOR CORE, AND ASSOCIATED COMPUTER PROGRAM PRODUCTS - A method for simulating the flow of a fluid in a vessel of a nuclear reactor is provided. The nuclear reactor includes the vessel and a core inside the vessel, the core including nuclear fuel assemblies, each one extending in an axial direction, including nuclear fuel rods and a grid for maintaining the rods, and being spaced apart from another by a clearance between the grids in a transverse direction. | 02-11-2016 |
Elodie Pacard, Lyon FR
Patent application number | Description | Published |
---|---|---|
20100094418 | METHOD FOR PREPARING A COMPOSITE MATERIAL, RESULTING MATERIAL AND USE THEREOF - The invention relates to a method for preparing a composite material having a homogeneous composition, containing at least one bioactive ceramic phase and at least one bioresorbable polymer. The inventive method is characterised in that it comprises the following steps: a) a bioactive ceramic phase in powder form is obtained, b) the bioactive ceramic powder is suspended in a solvent, c) a bioresorbable polymer is added to the suspension obtained in (b) and mixed to produce a viscous homogeneous dispersion of said bioactive ceramic powder in a solution formed by the solvent and the polymer, and d) the dispersion obtained in (c) is precipitated in an aqueous solution in order to obtain a homogeneous composite material. The invention also relates to the resulting composite material and to the use thereof in the production of implantable medical devices. | 04-15-2010 |
Elodie Pastural, Saskatoon CA
Patent application number | Description | Published |
---|---|---|
20120202188 | SERUM-BASED BIOMARKERS OF PANCREATIC CANCER AND USES THEREOF FOR DISEASE DETECTION AND DIAGNOSIS - Biomarkers of pancreatic cancer are described, as well as methods using these compounds for detecting pancreatic cancer. The methods can be used to diagnose a patient's health state, or change in health state, or for diagnosing risk of developing or the presence of pancreatic cancer. The method comprises analyzing a sample from a patient to obtain quantifying data for one or more than one of the metabolite markers; comparing the quantifying data to corresponding data obtained for one or more than one reference sample to identify abnormalities in the level of the metabolite marker(s) in the sample; and making a diagnosis if an abnormality is observed. Standards and kits for carrying out the method are also described. | 08-09-2012 |
Elodie Pettelot, Gourhel FR
Patent application number | Description | Published |
---|---|---|
20090098267 | USE OF INORGANIC PHOSPHATE COMPOUNDS AS PALATABILITY ENHANCERS OF FLAVOURS GENERATED BY THERMAL REACTIONS IN WET PET FOODSTUFFS - The present invention concerns means and methods for obtaining an edible or drinkable wet pet foodstuff having enhanced palatability, by heating an edible or drinkable foodstuff preparation comprising: —at least one inorganic phosphate compound, preferably at least one inorganic pyrophosphate; and—at least one thermal reaction-generated flavour and/or aminoacid and reducing sugar precursors thereof. | 04-16-2009 |
Elodie Pillet, Chamousset FR
Elodie Portales-Casamar, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20090280568 | S100B mini-promoters - Isolated polynucleotides comprising an S100B promoter are provided, where an S100B regulatory element is operably joined to an S100B basal promoter utilizing a non-native spacing between the promoter and regulatory elements. The promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, etc. | 11-12-2009 |
20100081201 | Olig1 mini-promoters - Isolated polynucleotides comprising an OLIG1 promoter are provided, where an OLIG1 regulatory element is operably joined to an OLIG1 basal promoter utilizing a non-native spacing between the promoter and regulatory elements. The promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, etc. | 04-01-2010 |
20100129903 | PITX3 EXPRESSION PROMOTERS - Isolated polynucleotides comprising a PITX3 promoter are provided, where a PITX3 regulatory element is operably joined to a PITX3 basal promoter utilizing a non-native spacing between the promoter and regulatory elements. The promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, etc. | 05-27-2010 |
20110097803 | CLDN5 Mini-Promoters - Isolated polynucleotides comprising a CLDN5 mini-promoter are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The mini-promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, etc. | 04-28-2011 |
20110136235 | MK167 Mini-Promoters - Isolated polynucleotides comprising an MKI67 mini-promoter are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The mini-promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, etc. | 06-09-2011 |
20140065666 | CLDN5 Mini-Promoters - Isolated polynucleotides comprising a CLDN5 mini-promoter are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The mini-promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, etc. | 03-06-2014 |
20140141517 | PCP2 Mini-Promoters - Isolated polynucleotides comprising a PCP2 mini-promoter are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc. | 05-22-2014 |
20140248701 | DCX MINI-PROMOTERS - Isolated polynucleotides comprising a DCX mini-promoters are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc. | 09-04-2014 |
20140256800 | FEV MINI-PROMOTERS - Isolated polynucleotides comprising a FEV mini-promoters are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc. | 09-11-2014 |
20140315987 | CHOLECYSTOKININ B RECEPTOR (CCKBR) MINI-PROMOTERS - Isolated polynucleotides comprising a CCKBR mini-promoters are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc. | 10-23-2014 |
20150240259 | PCP2 Mini-Promoters - Isolated polynucleotides comprising a PCP2 mini-promoter are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc. | 08-27-2015 |
20150259691 | UGT8 MINI-PROMOTERS - Isolated polynucleotides comprising a UGT8 mini-promoters are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc. | 09-17-2015 |
20150315609 | SLC6A4 MINI-PROMOTERS - Isolated polynucleotides comprising a SLC6A4 mini-promoters are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc. | 11-05-2015 |
20150343020 | TNNT1 MINI-PROMOTERS - Isolated polynucleotides comprising a TNNT1 mini-promoters are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc. | 12-03-2015 |
Elodie Quevrain, Vernou La Celle Sur Seine FR
Patent application number | Description | Published |
---|---|---|
20110046220 | PARABEN COMPOUNDS - The invention relates to a | 02-24-2011 |
Elodie Quevrain, Le Perreux Sur Marne FR
Patent application number | Description | Published |
---|---|---|
20150335705 | ANTI-INFLAMMATORY PEPTIDES - A polypeptide including or consisting of the amino acid sequence SEQ ID NO: 1, for use in the treatment or prevention of an inflammatory disease. A nucleic acid sequence encoding the polypeptide, a vector including the nucleic acid and a host cell including the nucleic acid sequence and/or a vector, for use in the treatment or prevention of an inflammatory disease are also described. A pharmaceutical composition including the polypeptide, the nucleic acid sequence, the vector or the host cell and a pharmaceutically acceptable carrier, for the treatment of inflammatory disease are also disclosed. | 11-26-2015 |
Elodie Raynaud, Mons BE
Patent application number | Description | Published |
---|---|---|
20130181363 | PROCESS FOR MANUFACTURING POLYSILOXANE MICROCAPSULES THAT ARE FUNCTIONALIZED AND ARE NOT VERY POROUS - A method is provided for encapsulating products that can have lipophilic or hydrophilic, including volatile, properties in a polysiloxane membrane that is particularly impervious. A method is also provided for evaluating the imperviousness of capsules. The present method includes the following steps: | 07-18-2013 |
20140234247 | Aminofunctional Organosiloxanes - Aminofunctional silicone compositions are disclosed comprising: an organopolysiloxane having an average formula of (CH | 08-21-2014 |
20140294746 | Aminofunctional Silicone Emulsions - Aqueous silicone emulsions are disclosed comprising: A) an aminofunctional organopolysiloxane, B) a quaternary ammonium surfactant having a formula R | 10-02-2014 |
20140308229 | Aminofunctional Silicone Emulsions For Fiber Treatments - Methods for treating fibers are disclosed with aqueous silicone emulsions comprising: A) an aminofunctional organopolysiloxane, B) a quaternary ammonium surfactant having a formula R | 10-16-2014 |
Elodie Roques, Montreal CA
Patent application number | Description | Published |
---|---|---|
20130287816 | P97 PROTEIN AND USES THEREOF AS VACCINE ADJUVANT - Immunogenic compositions comprising a p97 adhesin adjuvant polypeptide, or a nucleic acid encoding said p97 adhesin adjuvant polypeptide, and a heterologous antigen are disclosed. Uses of the p97 adhesin adjuvant polypeptide or nucleic acid, or immunogenic compositions comprising same, for inducing an immune response against a heterologous antigen in a subject are also disclosed. | 10-31-2013 |
Elodie Siband, Bruxelles BE
Patent application number | Description | Published |
---|---|---|
20150322291 | RADIATION CURABLE AQUEOUS COMPOSITIONS WITH REVERSIBLE DRYING - The present invention relates to an aqueous resin composition (I) comprising at least one polymerizable ethylenically unsaturated polyurethane polymer (A), optionally, at least one polymerizable ethylenically unsaturated compound (B) different from (A), and optionally, at least one neutralizing agent (C); wherein the polyurethane polymer (A) has a weight average molecular weight of less than 15.000 Daltons and is obtained from the reaction of: at least one polyisocyanate (i); at least one hydrophilic compound (ii) containing at least one reactive group capable to react with isocyanate groups and at least one group which is capable to render the polyurethane polymer dispersible or soluble in aqueous medium either directly or after reaction with a neutralizing agent (C) to provide a salt; at least one compound (iii) containing essentially one reactive group capable to react with isocyanate groups and at least one copolymerizable ethylenically unsaturated group; at least one compound (iv) containing at least two reactive groups capable to react with isocyanate groups; and, optionally, at least one chain extender (v) containing at least two reactive groups capable to react with isocyanate groups, which chain extender is different from compounds (iv); and wherein the non-volatile components of the resin composition (I) after drying are re-dispersible or re-soluble in water at 25° C. The present invention further relates to radiation curable compositions comprising a resin composition of the invention for use in coating applications or graphic art applications. | 11-12-2015 |
Elodie Sorlier, Paris FR
Patent application number | Description | Published |
---|---|---|
20080240879 | PROCESS FOR THE PRODUCTION OF AN ELEMENT COMPRISING AT LEAST ONE BLOCK OF DENSE MATERIAL CONSTITUTED BY HARD PARTICLES DISPERSED IN A BINDER PHASE: APPLICATION TO CUTTING OR DRILLING TOOLS - A process is presented which produces at least one block of dense material constituted by hard particles dispersed in a binder phase, it being possible for the dense material to be enriched locally with binder phase by imbibition. The process includes bringing at least one imbibition area of a surface of the block, preferably coated with a coating material, into contact with an imbibiting material which locally enriches the block with binder phase. The block in contact with the imbibiting material is then subjected to a suitable thermal cycle constituted by heating, temperature maintenance and cooling. This serves to bring some or all of the imbibiting material and the binder phase of the block into the liquid state in such a manner that the enrichment with binder phase takes place solely through the imbibition area. The block is used in connection with the building of a drill bit or tool. | 10-02-2008 |
20110174550 | PROCESS FOR MANUFACTURING A PART COMPRISING A BLOCK OF DENSE MATERIAL CONSTITUTED OF HARD PARTICLES AND OF BINDER PHASE HAVING A GRADIENT OF PROPERTIES, AND RESULTING PART - A block of dense material is made up of hard particles, of the same or different nature, dispersed in a binder phase. The material has a solidus temperature T | 07-21-2011 |
Elodie Sousan, Bern CH
Patent application number | Description | Published |
---|---|---|
20140161938 | FOOD-GRADE BLUE ENCAPSULATE AND PROCESS FOR THE PRODUCTION THEREOF - A food-grade blue encapsulate is disclosed, which comprises gelled proteins associated with metal ions and a colorant component. The colorant component comprises anthocyanins, anthocyanidins, or mixtures thereof. A process for producing the encapsulate is also disclosed. | 06-12-2014 |
Elodie Taboulot, Aubervilliers FR
Patent application number | Description | Published |
---|---|---|
20150114264 | Gypsum-Based Building Products and Method for the Manufacture Thereof - A building product comprises calcium sulphate dihydrate particles bound by an organic binder. The calcium sulphate dihydrate particles each have a longest dimension and a lateral dimension, wherein the lateral dimension corresponds to the maximum breadth of the particle about the axis defined by the longest dimension. The calcium sulphate dihydrate particles have a low aspect ratio such that for at least 75% of the calcium sulphate dihydrate particles, the value of the lateral dimension is at least 20% of the value of the longest dimension. | 04-30-2015 |
Elodie Tetard, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20140291162 | METHOD AND SYSTEM FOR TREATING CARBON GASES BY ELECTROCHEMICAL HYDROGENATION IN ORDER TO OBTAIN A CxHyOz COMPOUND - The present invention relates to a method for treating CO | 10-02-2014 |
20140302421 | ELECTRODE FOR ELECTROCHEMICAL CELL AND METHOD OF MANUFACTURING SUCH AN ELECTRODE - The invention relates to an electrode for an electrochemical cell which exhibits good electron conductivity and good chemical conductivity, as well as good cohesion with the solid electrolyte of the electrochemical cell. To do this, this electrode is made from a ceramic, which is a perovskite doped with a lanthanide having one or more degrees of oxidation and with a complementary doping element taken from the following group: niobium, tantalum, vanadium, phosphorus, arsenic, antimony, bismuth. | 10-09-2014 |
Elodie Tillier, Rueil Malmaison FR
Patent application number | Description | Published |
---|---|---|
20100332205 | METHOD OF MODIFIED FACIES PROPORTIONS UPON HISTORY MATCHING OF A GEOLOGICAL MODEL - A method of modifying a geological model representative of an underground reservoir is disclosed which respects average proportions of the lithologic facies imposed by a production data calibration process which has application to petroleum reservoir development. A geographical zone Z is defined within the geological model and an average proportion in zone Z allowing the production data to be calibrated is determined for k facies, with an optimization process. The proportions of these facies are modified using a block indicator cokriging method constrained by the average proportions to be respected. A new geological model constrained by the modified facies proportions is simulated and the development of the underground medium is optimized by the simulated model. | 12-30-2010 |
20120109597 | METHOD OF DEVELOPING A PETROLEUM RESERVOIR FROM HISTORY MATCHING OF PRODUCTION DATA AND SEISMIC DATA - A method of developing a petroleum reservoir from a reservoir model constrained by the production data and seismic attributes. Production data and seismic data are acquired during the development of the reservoir. A first image of a seismic attribute is constructed from the seismic data. Production responses are simulated from a reservoir model using a flow simulator. An image corresponding to the seismic attribute is simulated from the reservoir model. A local dissimilarity map is constructed from the reference seismic attribute image and from the simulated seismic attribute image. The reservoir model is modified to minimize any difference between the measured production data and the corresponding production responses and to minimize local dissimilarities. This model is used to determine an optimal development scheme and the reservoir is developed according to the development scheme. | 05-03-2012 |
Elodie Verdurand, Sisseln CH
Patent application number | Description | Published |
---|---|---|
20150011648 | PROCESS FOR THE MAINTAINING OF A RATIO OF ISOMERS OF CAROTENOID COMPOUNDS - The present invention relates to process for the maintaining of a ratio stereoisomers of carotenoid compounds, to specific formulations and to the use of such specific formulations. | 01-08-2015 |
Elodie Xuereb, Auch FR
Patent application number | Description | Published |
---|---|---|
20140255611 | PROCESS FOR THE ANTICORROSION TREATMENT OF A SOLID METAL SUBSTRATE AND TREATED SOLID METAL SUBSTRATE CAPABLE OF BEING OBTAINED BY SUCH A PROCESS - An anticorrosion treatment process in which applied to an oxidizable surface of a solid metal substrate is a liquid solution, referred to as treatment solution, including: at least one alkoxysilane, and at least one cerium (Ce) cation; in a liquid aqueous-alcoholic composition, the treatment solution being suitable for being able to form, at the surface of the solid metal substrate, a hybrid matrix by hydrolysis/condensation of each alkoxysilane(s) and of each cerium (Ce) cation; the treatment solution having a molar ratio (Si/Ce) of silicon element of the alkoxysilane(s) with respect to the cerium (Ce) cation(s) of between 50 and 500; characterized in that the cerium (Ce) cation(s) has(have) a concentration between 0.005 mol/L and 0.015 mol/L in the treatment solution. | 09-11-2014 |